Digital health start-up, Emperra, is the second to be supported by EIT Health and aescuvest crowdfunding platform.
According to the World Health Organisation, there are around 60 million people with diabetes in Europe and, if their condition is not managed correctly, sufferers are likely to become progressively ill, affecting their quality of life. Over time, diabetes can damage the heart, blood vessels, kidneys, eyes and nerves.
Emperra GmbH E-Health Technologies has developed the ESYSTA digital health technology which aims to support patients in recoding their blood glucose values and adhering to their treatment plans.
We combine all the important tools for recording, monitoring and evaluating diabetes treatment and to make them digitally available to patients and doctors using wireless connectivity. Nevertheless, the technology is very easy to use, which was especially important to us with regard to older patients.
Following initial success with institutional investors, Emperra is taking part in a public financing round on EIT Health-supported aescuvest.eu, which specialises in the healthcare sector.
The crowdfunding platform, which was launched jointly by EIT Health and aescuvest in August 2019 with a campaign for Surge-on-Medical, marked the start of a new means of public venture funding in Europe. By investing in healthcare innovations publicly accessible, EIT Health and aescuvest are using their Crowdfunding Platform to diversify the potential sources of funding and to allow citizens to invest in solutions that matter to them.
We are excited that our crowdfunding initiative is gaining traction with yet another fantastic case. It’s great to add a second company to our platform especially in an area much in need of innovation such as diabetes, which affects 60 million people in Europe.
Jan-Philipp Beck – CEO of EIT Health
To find out more and to invest, please visit aescuvest.